Nanosonics Limited (ASX:NAN)
Australia · Delayed Price · Currency is AUD 3.910
+0.060 (1.56%)
Feb 5, 2026, 4:10 PM AEST
Nanosonics Market Cap
Nanosonics has a market cap or net worth of 1.19 billion as of February 5, 2026. Its market cap has increased by 3.43% in one year.
Market Cap
1.19B
Enterprise Value
1.03B
Revenue
198.63M
Ranking
n/a
PE Ratio
58.45
Stock Price
3.91
Market Cap Chart
Since May 17, 2007, Nanosonics's market cap has increased from 151.14M to 1.19B, an increase of 684.75%. That is a compound annual growth rate of 11.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 1.19B | -1.51% |
| Dec 31, 2025 | 1.20B | 30.84% |
| Dec 31, 2024 | 920.45M | -30.92% |
| Dec 29, 2023 | 1.33B | 2.84% |
| Dec 30, 2022 | 1.30B | -31.96% |
| Dec 31, 2021 | 1.90B | -21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.60B |
| Pro Medicus | 17.38B |
| Cochlear | 17.00B |
| Sonic Healthcare | 11.26B |
| Neuren Pharmaceuticals | 1.85B |
| Clarity Pharmaceuticals | 1.10B |
| Integral Diagnostics | 961.60M |
| PYC Therapeutics | 933.22M |